We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

SDI Announces Participation of Berlex in Its Genomic Antibodies™ Initiative

SDI will provide polyclonal and monoclonal Genomic Antibodies™ to Berlex.
News

Dalton Pharma Services Announces Completion of its GMP Oligonucleotide Manufacturing Facility

Building on its 17 year history in oligonucleotide manufacture and analysis, Dalton can now use its expertise in synthesis and manufacturing of antisense oligonucleotides.
News

bmd Obtains FDA Approval for Four new FIDIS™ Diagnostic Kits for Autoimmune Diseases

Approval of FIDIS Connective 10, Vasculitis, Celiac IgC and Celiac IgA will boost bmd's penetration of the North American market
News

Expanded Access Program for Rexin-G™ Provides Genetic Medicine to Cancer Patients

The Expanded Access Program extends the clinical applications of the world's first targeted genetic medicine to many more cancer patients.
News

Industry Leaders and Investors Explore Better Business Models for the 'New Diagnostics' at Bio 2006

Experts will debate business models to support the growing potential of molecular diagnostics during a kick-off panel at BIO 2006.
News

Affitech Renews Worldwide Phage Display License From DKFZ for Breitling Patents

'Breitling' patents hold key position in human antibody discovery field.
News

Third Wave and Mitsubishi Announce Japanese Joint Venture for Personalized Medicine

Third Wave will accelerate and expand the development of high-value clinical products for the Japanese molecular diagnostic market.
News

Plexxikon Advances First Oncology Development Candidate

Preclinical data for oncogenic B-Raf inhibitor presented at American Association for Cancer Research Annual Meeting.
News

CFD Therapeutics Formed to Advance Monoclonal Antibodies for Cancer

diaDexus provided an exclusive license to CFD for its entire portfolio of therapeutic targets and associated monoclonal antibodies.
News

Ono and Medarex Enter into Second Antibody Development Collaboration

Anti-SDF-1 antibodies have been raised utilizing Medarex's UltiMAb Human Antibody Development System®.
Advertisement